Lower riskMedical device recall · FDA · Published April 15, 2024
CareFusion 303, Inc. - Product Catalog
CareFusion 303, Inc. is a leading manufacturer of medical devices and healthcare products. Explore their product catalog for detailed information on their latest innovations.
Potential fluid ingress of anesthesia station or med station may result in smoke, system downtime and/or fire.
Take action
Contact the company
📍Recalling firmCareFusion 303, Inc.10020 Pacific Mesa Blvd · San Diego, CA 92121-4386
✎ GovInfoNow plain-language explainer
CareFusion 303, Inc. is a leading manufacturer of medical devices and healthcare products. Explore their product catalog for detailed information on their latest innovations. Read more at govinfonow.com/recall/55394-carefusion-303-inc-product-catalog.
“CareFusion 303, Inc. - Product Catalog.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/55394-carefusion-303-inc-product-catalog. Based on FDA recall #Z-1932-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1932-2024%22&limit=1).
The FDA has classified an ongoing voluntary recall initiated by CareFusion 303, Inc. as a Class II recall.
How to tell if you have it
CareFusion 303, Inc.
The hazard
The hazard details are not specified in the provided text.
Context
CareFusion 303, Inc. has 64 other recalls on record since 2017-06-12. Recent recalls by CareFusion 303, Inc. include issues with BD Pyxis Anesthesia Station 40 fingerprint scanners overheating, labeling regarding Transport Layer Security versions for Point-of-Care Units, and software update issues with BD Pyxis ES Enterprise Server.
How to tell if you have this one
Check for updates and patches from CareFusion 303, Inc. to ensure the latest security features are implemented.
Brand
CareFusion 303, Inc.
Category
Medical device
FDA recall event · 6 products
All 6 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
Classification
Class II
Status
Ongoing
Distribution
Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MP, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY and the countries of South Africa, Kuwait, Qatar, Singapore, Bermuda, United Arab Emirates, Argentina, Australia, Belgium, Bahrain, Brazil, Bahamas, Canada, Chile, China, Germany, Spain, Finland, France, United Kingdom, Greece, Hong Kong, Ireland, Italy, Japan, South Korea, Lebanon, Morocco, Mexico, New Zealand, Oman, Portugal, Thailand, Taiwan.
What to do if you are using CareFusion 303, Inc. products
Ensure you are using the latest version of the product to benefit from the most recent security updates.
How to check for updates
Visit the CareFusion 303, Inc. website or contact their customer support for the latest updates.
Where it went and when
Where it was distributed
Distributed nationwide and abroad; the notice names 50 states.
Named in the notice
Covered by “nationwide”
Not listed
FDA distribution: “Worldwide - US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, GU, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MP, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC,…” States read from FDA’s own wording; “not listed” means the notice does not name it.
Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.
Recall timeline
FDA published this recall 51 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1932-2024 (April 15, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1932-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.